SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-23-000054
Filing Date
2023-05-11
Accepted
2023-05-11 16:04:20
Documents
84
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20230331.htm   iXBRL 10-Q 1104509
2 EX-31.1 sum-ex311_20230331xduggan.htm EX-31.1 11910
3 EX-31.2 sum-ex312_20230331xzanganeh.htm EX-31.2 11988
4 EX-31.3 sum-ex313_20230331xdhingra.htm EX-31.3 11996
5 EX-32.1 sum-ex321_20230331x10q.htm EX-32.1 11133
  Complete submission text file 0001599298-23-000054.txt   6262468

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20230331.xsd EX-101.SCH 56538
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20230331_cal.xml EX-101.CAL 67769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20230331_def.xml EX-101.DEF 216427
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20230331_lab.xml EX-101.LAB 566079
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20230331_pre.xml EX-101.PRE 404048
78 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20230331_htm.xml XML 894991
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 23910863
SIC: 2834 Pharmaceutical Preparations